Does competition from generics change lipitor's price?

Does competition from generics lower Lipitor's price?

Generics entered the market after Lipitor's patent expired in 2011. This competition dropped the price sharply, with some versions costing less than 10% of the brand-name price.

How does generic competition affect branded drug prices overall?

Generic competition usually drives down prices for both the brand and the copies. The brand owner may cut prices or offer discounts to retain market share. The average price drop for drugs facing generic entry ranges from 80% to 85% once several competitors are on the market.

What happened specifically to Lipitor after its patent expired?

After 2011, multiple manufacturers launched generic atorvastatin. Within a few weeks, the average price fell from around $150–$200 per month to below $15 per month for many patients. Brands sometimes kept a higher price for patients who remained loyal to the original.

When did Lipitor lose exclusivity?

Lipitor lost its primary U.S. patent protection in November 2011. Additional secondary patents expired shortly thereafter. Exclusivity ended completely once those rights cleared.

What happened to brand-name Lipitor sales and pricing strategy?

Brand-name sales fell 90% or more in the first year. Pfizer kept the original nameplate price high while offering large discounts through insurance and pharmacy programs. This mixed strategy helped capture some insurance-covered patients who still preferred the branded version.

Can other factors override generic competition on price?

Insurance coverage, copays, and pharmacy benefit managers can blunt or reverse apparent price drops. Some patients still face high out-of-pocket costs despite low net prices to payers.